Back to Journals » Journal of Asthma and Allergy » Volume 8

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

Total article views   HTML views PDF downloads Totals
22,071 Dovepress* 16,572+ 2,818 19,390
PubMed Central* 5,499 1,623 7,122
Totals 22,071 4,441 26,512
*Since 8 October 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar